Correlation Between Pfizer and Ternium SA

Can any of the company-specific risk be diversified away by investing in both Pfizer and Ternium SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Ternium SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Ternium SA DRC, you can compare the effects of market volatilities on Pfizer and Ternium SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Ternium SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Ternium SA.

Diversification Opportunities for Pfizer and Ternium SA

0.82

Correlation Coefficient

Pfizer  Ternium SA

Very poor diversification

The 3 months correlation between Pfizer and Ternium is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Ternium SA DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ternium SA DRC and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Ternium SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ternium SA DRC has no effect on the direction of Pfizer i.e., Pfizer and Ternium SA go up and down completely randomly.

Pair Corralation between Pfizer and Ternium SA

Assuming the 90 days trading horizon Pfizer Inc is expected to under-perform the Ternium SA. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.24 times less risky than Ternium SA. The stock trades about -0.29 of its potential returns per unit of risk. The Ternium SA DRC is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  1,020,000  in Ternium SA DRC on September 12, 2024 and sell it today you would lose (158,000) from holding Ternium SA DRC or give up 15.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  Ternium SA DRC

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Ternium SA DRC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ternium SA DRC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Pfizer and Ternium SA

The main advantage of trading using opposite Pfizer and Ternium SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Ternium SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ternium SA will offset losses from the drop in Ternium SA's long position.

The idea behind Pfizer Inc and Ternium SA DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..